WAKETTA ALDRIDGE: Open Payments
NPI 1588297972 · JONESBORO, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,349 in 45 payments from 11 companies in 2025. Trend: 2023 $577 · 2024 $398 · 2025 $1,349
Food & beverage: $1,349
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 4 | $258 |
| ABBVIE INC. | 13 | $222 |
| Novartis Pharmaceuticals Corporation | 14 | $207 |
| Novocure Inc. | 2 | $202 |
| Amgen Inc. | 5 | $113 |
| Janssen Biotech, Inc. | 2 | $110 |
| Aveo Pharmaceuticals, Inc. | 1 | $93 |
| Astellas Pharma US Inc | 1 | $89 |
| Daiichi Sankyo Inc. | 1 | $22 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $18 |
Products named: Optune Lua (NovoTTF-200T), EPKINLY, FOTIVDA, RYBREVANT, Vyloy, Fabhalta, RINVOQ, OTEZLA.
Industry payments across AR — which companies pay providers there.
